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CHAPTER I. INTRODUCTION 
Endogenous ovarian hormone secretions are believed to 
be partially responsible for inhibiting lactogenesis during 
pregnancy. The administration of ovarian steroids during 
lactation will inhibit lactational performance. The inhibi­
tory potencies of estrogen and progesterone are different 
during lactogenesis and lactation. 
Circulating progesterone is partially responsible for 
preventing lactogenesis during mid-pregnancy, presumably by 
inhibiting alpha-lactalbumin synthesis. During lactation 
circulating progesterone and exogenous progesterone do not 
inhibit lactational performance. 
Exogenous estrogen does not inhibit lactogenesis- Exo­
genous estrogen will, however, depress lactational performance 
when administered to intact lactating animals. The ovaries 
are necessary for estrogen's inhibitory potency during lac­
tation since estrogen will not inhibit lactational per­
formance in ovariectomiz-ed animals, if, however, both estro­
gen and progesterone are administered to ovariectomized 
lactating animals, then lactational performance can be 
depressed. 
Inhibition of lactational performance by exogenous 
ovarian steroids is characterized by a latent period of five 
to sôven days in which litter growth is normal. Following 
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this period litter growth is inhibited; the extent of inhi­
bition is directly related to the amount of hormone ad­
ministered. The inhibition of litter growth can be re­
versed by the suspension of ovarian hormone treatment, and 
litter growth rates return to normal. 
Litter growth depression as observed during the ad­
ministration of ovarian steroids probably alters the func­
tion of the mammary gland because of end product inhibition 
of milk secretion, and decreased release of lactogenic hor­
mones, making it difficult to assess the direct effects of 
ovarian steroids on the mammary gland. 
The functioning of the lactating rat mammary gland during 
ovarian steroid treatment has only been studied superficial­
ly. To date mammary gland involution, mammary gland growth, 
rsducsd milk production and normal milk production have been 
reported. 
This investigation was conducted to determine whether 
estrogen-progesterone treatment affected the mammary gland 
directly and to determine the nature and cause of any 
alterations in mammary gland function. Mammary gland 
function was studied by measuring mammary gland nucleic acid 
levels and synthesis, and milk composition, and through 
histological examination of the mammary glands. Litter 
growth rates were closely monitored to insure that changes 
in litter vitality could not bias the results. 
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CHAPTER II. LITERATURE REVIEW 
Effects of Ovarian Hormones on Mammary 
Gland Growth 
Studies in vivo^ pituitary intact animals 
Regression of the mammary glands after ovariectomy was 
the first information indicating ovarian involvement in 
mammary gland growth. The discovery of Grigorieff (1897) 
that ovarian transplantation prevented mammary gland re­
gression following ovariectomy established the hormonal 
nature of ovarian involvement in mammary gland growth. 
Corpora lutea involvemient in mammary gland growth was 
suggested by Ancel and Bouin (1911). These researchers 
observed a correlation between luteal tissue development and 
mammary gland growth during pregnancy and the estrous cycle. 
Laquer, De Jongh and Tausk (1S27) reported that sstrogsn 
•I 
stimulated mammary gland growth in the rat. Turner and 
Schultze (1931) and Astwood, Geschickter and Rausch (1937) 
indicated the growth promoting effects of estrogen were 
restricted to the mammary gland ducts, while combinations 
of estrogen and progesterone promoted lobular alveolar 
mammary gland growth. 
Progesterone has little growth promoting activity when 
administered at physiological levels (Turner and Schultze 
1931). Large doses of progesterone can promote mammary 
gland growth in the rat (Selye 1940a,b; Reece and Bivins 1942). 
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Mixner and Turner (1942); suggested the progesterone sparing 
concept. This concept is that estrogen makes the mammary 
gland more sensitive to progesterone. 
The ratio of estrogen to progesterone is critical for 
optimum mammary gland proliferation. For optimum mammary 
gland growth, progesterone concentrations must be at least 
one thousand times greater than estrogen concentrations 
(Elliot and Turner 1953). If estrogen-progesterone ratios 
are below the minimum level, resulting mammary gland growth 
is predominantly in the ductal system. 
DNA determination, used as an index of mammary gland 
development, has allowed the growth response of the mammary 
gland to be quantitated during ovarian hormone administra­
tion. Estradiol benzoate treatment causes little mammary 
gland growth (Moon, Griffith and Turner 1959; Damm, Miller 
and Turner 1961). Prolonged estradiol treatment for periods 
of forty and sixty days evokes no more mammary gland de­
velopment than twenty days treatment (Panda and Turner 1966), 
Progesterone treatment, at physiological levels, does not 
increase mammary gland DNA levels (Moon, Griffith and Turner 
1959). 
Estradiol benzoate-progesterone treatment has a pro­
nounced growth-promoting effect upon the mammary glands of 
ovariectomized rats. Moon, Griffith and Turner (1959) found 
that daily estradiol-progesterone treatment produced mammary 
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gland proliferation in ovariectomized rats equal to mammary 
gland growth in pregnant animals. Other researchers re­
port similar results with estradiol-progesterone treatment 
including: Damm, Miller and Turner (1961), Griffith, 
Williams and Turner (1963), Griffith and Turner (1963), 
and Ferreri (1971). Prolonged estradiol-progesterone 
treatment/ for periods ranging to sixty days, produces 
slightly more mammary gland growth than twenty days of 
estradiol-progesterone treatment (Damm, Miller and Turner 
1961). 
Estrogen treatment increases the rate of mammary gland 
DNA synthesis and the number of mammary gland mitoses. 
Estrogen treatment eventually causes cyclic mitotic activity 
in the mammary gland with a periodicity of five to eight 
days (Bresciani 1971)^ 
Estrogen^prcgesterone treatment increases mitotic ac­
tivity in the mammary gland (Traurig and Morgan 1964). These 
hormones double the rate of mammary gland DNA synthesis 
(Bresciani 1965). 
Studies in vivo, hypophysectoïnised animals 
Estrogen (Reece, Turner and Hill 1936) and estrogen-
progesterone combinations (Gomez and Turner 1936) do not 
cause mammary gland growth in hypophysectomized rats. 
Estradiol-progesterone treatment does not increase mammary 
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gland DNA levels in hypophysectomized rats (Hahn, Anderson 
and Turner, unpublished). 
Mammary gland growth can be produced in hypophysectomized 
rats or hypophysectomized-adrenalectomized-ovariectomized 
rats with pituitary gland hormones, estrogen and progester­
one. Lyons and associates stimulated maximal mammary gland 
growth in triply operated rats with the combination of 
hormones: estrogen, progesterone, growth hormone and pro­
lactin (Lyons, Li and Johnson 1958). 
Ahren and Jacobsohn (1956) induced mammary gland growth 
in hypophysectomized rats with estrogen, progesterone and 
long acting insulin. 
Hahn, Anderson and Turner (unpublished) quantitated experi­
mental mammary gland growth in hypophysectomized rats by DNA 
itsëâSureïûsnto Sypophysectoisy redussd rsansnery gland DNA levels 
seventy-five per cent. Several hormone treatments, including 
growth hormone, insulin, and estradiol-progesterone, did not 
increase mammary gland DNA to virgin levels. Prolactin, and 
hormone combinations containing prolactin, increased mammary 
gland DNA above virgin levels. The hormone combination pro­
ducing maximal mammary gland growth contained estradiol, 
progesterone, thyroxine, cortisone, growth hormone, and 
prolactin. This treatment produced mammary gland develop­
ment equal to mammary gland development in a rat pregnant 
for fifteen days. If one or two hormones were omitted from 
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this combination, mammary gland development was not as ex­
tensive. These hormones and the reduction from optimum 
growth were: prolactin 35%, progesterone 19%, growth 
hormone 11%, and estradiol-progesterone 22%. 
Studies in vitro 
Estradiol benzoate has been shown to accelerate the cell 
cycle of mammary gland cells in culture, thus increasing 
cell division rates. Estradiol concentrations must be in 
the physiological range to accelerate the cell cycle, and 
concentrations above or below the physiological range slow 
the cell cycle. The cell cycle is presumably stimulated 
through an increase in DNA polymerase activity (Lockwood, 
Stockdale and Topper 1967). Other estrogenic compounds also 
stimulate mammary gland DNA polymerase activity including 
estradiol, diethylstilbesterol, and estrone (Turkington and 
Hilf 1968). Progesterone in contrast has no effect on 
mammary gland DNA synthesis iji vitro (Turkington, Juergens 
and Topper 1967)« 
Ovarian hormones have not been shown to cause mammary 
gland cell division ^  vitro. Turkington and associates have 
found insulin and serum epithelial growth factor to cause 
mammary gland cell division ^  vitro (Majumder and Turking­
ton 1971; Turkington 1972). Several workers have stimu­
lated mammary gland mitotic activity in vitro with prolactin 
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(El-Darwish and Rivera 1970; Dilley 1971), while other re­
searchers have been unable to stimulate mammary gland DNA 
synthesis with prolactin treatment (Hallowes, Wang and Lewis 
1973). 
Mammary gland growth during lactation 
During the first five days following parturition there 
is ah increase in mammary gland DNA levels (Griffith and 
Turner 1959; Griffith and Turner 1961? Tucker and Reece 
1963). Since mitotic activity in the mammary gland is in­
tense during this period, it is likely that the increases in 
mammary gland DNA represent mammary gland growth (Traurig 
1967). Morphometric studies also support this concept 
suggesting an increase in the number of cells per mammary 
gland alveolus (Munford 1^64). 
Ovarian steroids and the ovaries have no role in post­
partum mammary gland growth. Griffith and Turner (1962) and 
Tucker, Paape and Sinha (1967) indicate that ovariectomy 
did not inhibit postpartum mammary gland growth. The 
ovaries are, however, necessary for mammary gland growth 
during lactation when suckling is intense (Tucker, Paape and 
Sinha 1967). 
The maintenance of mammary gland size does not require 
the presence of the ovaries (Griffith and,Turner 1962), and 
lactational performance is not affected by ovariectomy 
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(Kuramitsu and Loeb 1921). 
Pituitary hormones seem to be responsible for promoting 
postpartum mammary gland growth. Hypophysectomy will pre­
vent postpartum mammary gland growth, and exogenous pro­
lactin will stimulate mammary gland DNA synthesis and will 
increase 32P incorporation rates to levels near those of 
normal lactating rats.(Baldwin and Martin 1968). Agreement 
on the role of prolactin in postpartum mammary gland growth 
is not universal. Sinha, Lewis and Vanderlaan (1972) con­
sider growth hormone the primary stimulator of postpartum 
mammary gland growth. 
Summary 
The roles of the pituitary hormones and the ovarian 
steroids in promoting mammary gland growth are not yet 
resolved. Several theories have been advanced as answers to 
this question. Currently none of the theories has been 
conclusively proven. 
Gomes and Turner (1937) postulated an indirect role for 
the ovarian hormones in mammary gland growtha These workers 
believed ovarian hormones caused the release of special 
mammogenic hormones from the pituitary gland. Specific . 
mammogens do not exist, but the ovarian hormones do cause the 
release of prolactin from the pituitary gland (Chen and 
Meites 1970). 
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Jacobsohn (1961> postulated the role of the pituitary 
gland in mammary gland growth was a permissive maintenance 
of boood metabolite levels. Her postulation is probably 
partially correct, because hypophysectomy is followed by a 
rapid loss of body weight (Engel 1954) and mammary gland 
regression (Hahn, Anderson and Turner, unpublished). Jacob­
sohn' s postulation is also supported by nutritional studies. 
Mammary gland growth in response to estrogen treatment is 
prevented by low food intake (Ferguson 1956). The ability 
of the mammary gland to respond to estrogen is dependent on 
food intake. As food intake is decreased, more estrogen is 
needed to obtain a growth response (Trentin and Turner 1941). 
Anterior pituitary hormones can promote mammary gland 
growth directly vivo. Talwalker and Meites (1961) re­
ported prolactin-growth hormone treatment to cause lobular-
alveolar mammary gland development in adreno-ovariectomized 
hypophysectomized rats. Pituitary gland transplants or 
mammotropic pituitary tumors can produce lobular-alveolar 
mammary gland growth in hypophysectoroized rats in the im­
mediate vicinity of the transplants (Meites and Kragt 1964; 
Talwalker and Meites 1964). Hahn, Anderson and Turner 
(unpublished) reported an eighty-five per cent increase in 
meimmary gland DMA resi^lting from daily prolactin administra­
tion to hypophysectomized rats. When compared to intact 
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Virgin animals the increase in mammary gland growth is ten 
per cent. 
Insulin does not cause mammary gland growth by itself 
in vivo. Mammary gland growth in pregnant rats can be 
augmented slightly by insulin administration. Insulin-
thyroxine treatment of pregnant animals increases mammary 
gland growth twenty per cent, while insulin-growth hormone 
treatment of pregnant rats increases mammary gland growth 
sixty-two per cent (Kumaresan and Turner 1966), 
Direct stimulation of mammary gland growth by ovarian 
hormones has been demonstrated ^  vivo. Local mammary gland 
growth responses can be produced by topical estrogen ad­
ministration to the skin overlying the mammary glands. The 
presence of the pituitary gland is required for this process 
in many species (Polley and Malpress 1948) but not in the 
rabbit (Jacobsohn 1961). Ovariectomy prevents allometric 
mammary gland growth during puberty (Cowie and Polley 1961; 
Cowie 1949). Cytoplasmic estrogen receptors exist in the 
mouse mammary gland, indicating that estrogen can directly 
affect the mammary gland (Shyamala and Nandi 1972). 
Most of the evidence in the literature indicates that 
the ovarian hormones have a direct role in promoting mammary 
gland growth during pregnancy, probably acting in a syner­
gistic fashion with prolactin and growth hormone. Meites 
(1966) has postulated that the ovarian hormones make the 
12 
mammary gland sensitive to the anterior pituitary hormones 
prolactin and growth hormone. 
During lactation mammary gland growth is independent 
of ovarian steroid stimulation. The anterior pituitary 
hormones are the main stimulators of mammary gland growth 
and are released in reponse to the suckling stimulus. 
Effects of Ovarian Hormones on Mammary Gland 
Function During Lactogenesis and Lactation 
Effects of estrogen and or progesterone oh lactogenesis 
During mid or late pregnancy ovariectomy allows pre­
mature lactogenesis in rats. Lactose production begins in 
the mammary glands shortly after the ovaries are removed. 
Hysterectomy also causes premature lactogenesis in the rat, 
but the appearance of lactose in the mammary glands is 
slower than after ovariectomy (Lui and Davis 1967, Shinde, 
Ota and Yokoyama 1965, Yokoyama, Shinde and Ota 1969; Kuhn 
1969a,b). 
Kuhn (1969b) reported that progesterone administration 
could prevent premature lactogenesis and lactose formation 
induced by ovariectomy of rats during the last two or three 
days of pregnancy. Kuhn also reported that lactose forma­
tion normally occurring during the last two days of preg­
nancy could be prevented by progesterone administration. 
In vitro, progesterone prevents alpha lactalbumin 
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formation in mammary gland cell cultures (Turkington and 
Hill 1969). Ovarian hormones can prevent lactogenesis in 
dog mammary gland expiants (Barnawell 1967) and in mouse 
mammary gland cultures (Turkington, Brew, Vanaman and Hill 
1968). 
In vivoy estrogen-progesterone administration prevents 
lactogenesis in rabbit mammary glands treated with intraductal 
prolactin injections (Meites and Sgouris 1953, 1954). These 
workers observed that both estrogen and progesterone were 
required to block lactogenesis and that the dosages of 
ovarian hormones were of the same magnitude as those pro­
moting mammary gland growth, and the inhibitory effects of 
estrogen-progesterone treatment could be overridden by 
increasing the amount of prolactin administered intraductal­
ly. 
The findings of Meites and Sgouris have been confirmed 
by Denamur and Delouis (1972)/ who prevented prolactin-induced 
lactogenesis in pseudopregnant rabbits with estrogen-pro-
gesterone treatment. 
Estrogen administration has no inhibitory effect on 
lactogenesis (Denamur 1971). Estrogen treatment can induce 
lactogenesis and can induce lactation in rabbits, goats and 
cows. Estrogen is believed to promote lactogenesis and 
lactation by increasing synthesis and release of prolactin 
(Folley and Malpress 1948, Meites and Turner 1948a, Meites 
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1961; Meites 1966). 
Although a theory explaining the induction of lactation 
is considered "foolhardy" by Denamur (1971), the theory of 
Meites (1966) explains most of the factors important in 
controlling lactogenesis in the rat. Meites' theory 
follows ; 
a. During pregnancy there is insufficient prolactin, 
adrenal corticoids or both to initiate lactation. 
b. Estrogen and progesterone which are secreted in 
large quantities during pregnancy render the 
mammary gland refractory to stimulation by 
prolactin and glucocorticoids. 
c. At parturition there is a rise in circulating 
prolactin emd glucocorticoids and a fall in 
estrogen and progesterone permitting the onset 
of lactationc 
Meites suggests that parts a and c of his theory are the 
most important controlling factors regulatino lactogenesis. 
Ovarian activity during lactation 
The rat undergoes a postpartum ovulation and if mated 
at this ovulation, delayed implantation (Kirkham 1910). A 
luteinnizing hormone surge sometime during the first day post­
partum triggers ovulation (Rebar, Nakane and Midgley 1969). 
Delayed implantation is probably caused by a deficiency in 
estrogen secretion (Yoshinaga 1961), The length of the delay 
in implantation is directly related to the number of suck­
ling young, suggesting that the nursing stimulus is 
partially responsible for delayed implantation (Mantalenakis 
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and Ketchel 1966). 
Except for the postpartum ovulation there is no folli­
cular development during lactation in the rat. Vaginal 
smears have the appearance of diestrous smears (Long and 
Evans 1922). 
Ovarian weights decrease through lactation, and the 
weight decrease is related to the number of suckling young 
(Rothchild and Dickey 1960). The ovaries contain two sets of 
corpora lutea. The corpora lutea formed at the postpartum 
ovulation are functionally active and are similar in ap­
pearance to those found in pseudopregnant animals. The 
corpora lutea from the previous pregnancy are inactive and 
regress (Long and Evans 1922). 
The corpora lutea from the postpartum ovulation secrete 
progesterone in sufficient quantities so that a decidual 
response can be evoked in the uterus (Long and Evans 1922; 
Lyon 1939). The corpora lutea also secrete 20-a-hydroxy-
pregn-4-ene-3-one (20 HP). Quantities of progesterone and 
20 HP are inversely related. Progesterone secretion in­
creases from low levels at the start of lactation, increases 
to maximum levels on day twelve, then decreases to low levels 
by day sixteen (Yoshinaga, Modgal and Creep 1971; Labhsetwar 
and Watson 1974). Progesterone secretion is directly related 
to the strength of the nursing stimulus, and as litter size 
is increased progesterone secretion increases (Yoshinaga 
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et al. 1971). 
Estrogen secretion is very low during lactation (Selye, 
Collip and Thomson. 1935, Greenwald 1958; Labhsetwar and 
Watson 1974). 
The effects of suckling on ovarian function are mediated 
by changes in gonadotropin secretion. Suckling decreases LH 
and FSH secretion and elevates prolactin secretion (Declin 
1947, Rothchild 1960; McCann, Graves and Talenski 1961; 
Ford and Melampy 1973). Although LH secretion is depressed, 
there seems to be enough LH present to allow progesterone 
secretion by the ovaries. If LH antiserum is administered 
to lactating rats, circulating progesterone levels decrease 
(Yoshinaga et 1971) . 
Effects of ovarian hormones on lactational performance 
Kuramitsu and Loeb (1921) observed that ovariectomy did 
not adversely affect lactation. Richter (1936) indicated that 
ovariectomy could not prolong lactation. Ovariectomy during 
lactation does not inhibit mammary gland growth or affect 
the maintenance of mammary gland size (Griffith and Turner 
1962). These findings suggest that the ovaries are not 
involved in the lactational process, 
Ovarian hormone administration during lactation in­
hibits lactational performance. Parkes and Bellerby (1927) 
first demonstrated the effects of estrogen treatment on 
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lactational performance. De JOngh (1933) found that chorionic 
gonadotropin inhibited lactational performance. 
The ovaries mediate the action of estrogen and chorionic 
gonadotropin on lactational performance. Ovariectomy pre­
vents the inhibitory effects of exogenous estrogen on 
lactational performance (Anselmino and Hoffmann 1936). Edel-
mann and Gaunt (1941) indicated that ovariectomy blocked the 
inhibitory effects of chorionic gonadotropin on lactational 
performance. Polley and Kon (1937) reported that estrogen 
treatment could inhibit lactational performance in ovariecto-
mized animals. 
The results of these early investigations concerning 
ovarian hormone inhibition of lactational performance have 
been confirmed in numerous investigations. Results similar 
to those obtained in rats have been obtained in rabbits, 
guinea pigs, cows and humans. These investigations have been 
suïïfinarized in the reviews of Nelson (1836), Turner (1939), 
Folley and Malpress (1948), Cowie (1961) and Cowie and 
Folley (1961). 
Table 1 is a summary of some of the research conducted 
with estrogenic compounds in intact rats. The reports of 
several workers suggest a dose response relationship between 
the amount of estrogen administered and the inhibition of 
lactational performance (Barsantini and Masson 1947, Walker 
and Matthews 1949, Ben David et al. 1965; Gala and Reece 1962). 
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Table 1. Estrogen, intact animals 
Treatment Observation Source 
1000 lu® progynon b^ 
per day, days 1-15 
Pup growth reduced after 5-6 
days, increased pup mortality 
Anselmino & 
Hoffmann 1936 
100 ru progynon b per 
day, days 1-till growth 
stopped 
Litter weight depressed 32%, 
mammary gland mitotic 
activity stimulated 
Reece et al. 
1940 
1 mg Ep per day, 
days 1-16 
Litter weight depressed 34%, Edelmann & 
pup mortality 66% Gaunt 1941 
1 mg S per day, days 
1-16 
Litter weight depressed 39%, 
pup mortality 75% 
S 12 mg total, 
days 1-7 
Litter weight depressed, 
mammary secretion decreased, 
pup mortality 38% 
Meites & 
Turner 1942 
1 mg per day, 
days 1-14 
1 pellet^ Eb^ in 
skin, days 1-16 
Litter weight depressed, 
after 5 days 
Litter weight reduced 34%, 
pup mortality 60% 
Weichert & 
Kerrigan 1942 
Barsantini 
et al. 1946 
2 pellets Eb in 
skin, days 1-16 
Litter weight reduced 49%, 
pup mortality 49% 
10 mg Eb per day, 
days 1-10 
Litter weight depressed 100%, 
pup mortality 100% 
Barsantini & 
Masson 1947 
*One lu is 0,1 ng estrone. 
^E estrone. 
'ru rat unit. 
Ep estradiol propionate. 
'S stilbesterol. 
One pellet contains 10 mg estradiol. 
Eb estradiol benzoate. 
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Table 1 (Continued) 
Treatment Observation Source 
1 mg Eb per day, 
days 1-16 
10 pg Eb per day, 
days 1-16 
1 mg S per day, 
days 2-16 
200 yg S per day, 
days 2-16 
100 yg E^ per day, 
days 2-16 
25 yg E per day, 
days 2-16 
5 |ig E psr day, 
days 2-16 
Litter weight 
pup mortality 
Litter weight 
pup mortality 
Litter weight 
pup mortality 
Litter weight 
pup mortality 
Litter weight 
pup mortality 
Litter weight 
pup mortality 
depressed 46%, 
66% 
depressed 35%, 
25% 
depressed 36% 
75% 
depressed 37%, 
75% 
depressed 25%, 
50% 
depressed 28%, 
50% 
Walker s 
Matthews 1949 
Litter weight depressed 4S%, 
pup mortality 0% 
1 yg Eb per day, 
day 2 till growth 
stopped 
Litter weight depressed 12%, Gala & 
mitotic activity stimulated Reece 1962 
10 yg Eb per day, 
day 2 till growth 
stopped 
Litter weight depressed 36%, 
mitotic activity stimulated 
10 yg Eb and oxytocin 
3X per day 2 till 
growth stopped 
1 yg Eb per day, 
days 1-14 
300 yg Eb per Kg 
per day, days 7-20 
100 yg Eb per Kg 
per day, days 7-20 
Litter weight depressed 48%, 
mitotic activity stimulated 
Litter weight depressed 26%, 
milk present in mammary glands 
Litter growth depressed 100%, 
pup mortality 100% 
Litter growth depressed 100%, 
pup mortality 100% 
Griffith & 
Turner 1962 
Ben David 
et al. 1965 
^E estrone. 
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Table 1 (Continued) 
Treatment Observation Source 
.030 iJg Eb per Kg 
per day, days 7-20 
Litter growth depressed 91%, 
pup mortality unreported, 
milk yields reduced 
.010 ]ig Eb per Kg 
per day, days 7-20 
Litter growth depressed 40%, 
milk yields reduced 
.003 yg Eb per Kg 
per day, days 7-20 
Litter growth depressed 9%, 
milk yields normal 
.001 yg Eb per Kg 
per day, days 7-20 
Litter growth stimulated 14%, 
milk yields stimulated 
.010 yg Eb per Kg 
per day, days 7-16 
suspended to day 20 
Litter growth depressed then 
re-established when treatment 
suspended 
Estradiol implant, 
back 
Litter growth depressed 30% Bruce & 
Ramirez 1970 
Estradiol inplant, 
mammary gland 
Litter growth depressed 50-
90% 
Estradiol inplant, 
pituitary gland 
Litter growth normal 
Both physiological and pharmacological doses of estrogenic 
compounds suppress lactational performance in intact rats. 
Research conducted with estrogenic compounds in ovari-
ectomized rats is summarized in Table 2. Lactational per­
formance can be suppressed in ovariectomized rats only 
by pharmacological doses of estrogen. Physiological doses 
of estrogen do not affect lactation (Qriffith and Turner 
1962). 
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Table 2. Estrogen, ovariectomized animals 
Treatment Observations Source 
1000 lu^ progynon b^ Litter weight normal. Anselmino & 
per day, days 1-5 pup mortality 0% Hoffmann 1936 
1 mg Ep® per day. Litter weight depressed 36%, Edelmann & 
days 1-16 pup mortality 33% Gaunt 1941 
1 mg per day. Litter weight depressed 31%, 
days 1-16 pup mortality 33% 
2 pellets® Eb^ in Litter weight reduced 15%, Barsantini 
skin, days 1-16 pup mortality 9% et al. 1946 
1 mg Eb per day. Litter weight depressed 4%, Barsantini & 
days 1-16 pup mortality 9% Masson 1947 
10 yg Eb per day. Litter weight normal. 
days 1-16 pup mortality 9% 
10 yg Eb per day. Litter weight normal Masson 1948 
days 1-15 
1 mg S per day, Litter weight depressed 26%, Walker & 
days 2-16 pup mortality 50% Matthews 1949 
200 yg S per day. Litter weight depressed 10%, 
days 2-16 pup mortality 25% 
200 yg E^ per day, Litter weight depressed 10%, 
days 2-16 pup mortality 0% 
^One lu is 0.1 jig estrone. 
Jj 
.:,E estrone. 
^ru rat unit 
'^Ep estradiol propionate. 
stilbesterol. 
^One pellet contains 10 rag estradiol. 
^Eb estradiol benzoate. 
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Table 2 (Continued) 
Treatment Observations Source 
100 yg per day, Litter weight depressed 8%, 
days 2-16 pup mortality 0% 
1 yg Eb per day, Litter weights normal. Griffith S 
days 1-14 milk in mammary glands Turner 1962 
estrone. 
Progesterone treatment does not alter lactational per­
formance unless massive doses are administered (Table 3) 
(Barsantini and Masson 1947). 
Estrogen-progesterone treatment inhibits lactational 
performance in intact animals. These hormones are effective 
in physiological doses (Table 4). 
Estrogen-progesterone treatment inhibits lactational 
performance in ovariectomized rats (Table 5). Estrogen-
progesterone treatment is effective in ovariectomized rats 
when administered in physiological and pharmacological doses. 
The inhibition of lactational performance by estrogen-
progesterone treatment is not as extensive in ovariectomized 
rats as is the inhibition observed in intact rats with equal 
estrogen-progesterone doses. There is a dose response 
relationship between the quantity of estrogen-progesterone 
and the inhibition of lactational performance in ovariectomized 
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Table 3. Progesterone, intact animals 
Treatment Observations Source 
Extracts of 1/4 to 
1/2 corpra lutea 
per day 
1 mg per day, 
days 5-20 
10-15 mg P per 
days 
10 mg P per day, 
days 1-16 
25 mg P per day, 
days 1-16 
2 mg P per day, 
days 2-16 
5 mg P per day, 
days 2-16 
3 mg P per day, 
days 1-14 
100 mg P per kg 
per day, days 7-20 
Litter growth normal 
Litter weight normal 
Litter weight normal 
Litter weight normal 
Litter weight depressed 25% 
Litter weight normal 
Litter weight normal 
Litter weight normal 
Litter growth normal 
Anselmino & 
Hoffmann 1936 
Folley & 
Kon 1937 
Folley 1942 
Barsantini & 
Masson 1947 
Walker s 
Matthews 1949 
Griffith & 
Tuïiièjt 1362 
Ben David 
et al. 1965 
a 
P progesterone. 
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Table 4. Estrogen-progesterone, intact animals 
Treatment Observations Source 
1 pellet Eb^ and Litter weight depressed 70% Barsantini 
2 pellets in et al^. 1946 
skin, days 1-16 
1 pellet Eb and 4 Litter weight reduced 41%, 
pellets P implanted pup mortality 78% 
in skin, days 1-16 
c â 
1 yg Eb and 3 mg P 
per day, days 1-14 
1 lig Eb and 3 mg P 
per day, days 1-14 
1 pg Eb and 3 mg P 
per day, days 1-4 
Litter weight depressed 
milk present in mammary 
Litter weight depressed 
milk present in mammary 
37%, Griffith & 
glands Turner 1962 
14%, Kodson 1971 
glands 
Walker 1972 Mammary gland structure normal 
1 lig Eb and 3 mg P 25% of the mammary gland 
per day, days 1-9 altered histologically, 
decreased evidence of 
secretion 
1 yg Eb and 3 mg P Majority of mammary gland 
per day, days 1-14 altered histologically, 
decreased evidence of secretion 
and structural degradation 
^Eb estradiol benzoate pellet, 10 mg. 
~p progesterone pellet, 40 mg. 
c 
Eb estradiol benzoate. 
d 
P progesterone. 
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Table 5. Estrogen-progesterone, ovariectomized animals 
Treatment Observation Source 
1 mg S® and 2 mg P^ 
per day, days 1-16 
Litter weight depressed 48%, 
pup mortality 25-100% 
Edelmann & 
Gaunt 1941 
1 pellet Eb*^ and 2 
pellets P*^ in skin, 
days 1-16 
Litter weight depressed 26% 
pup mortality 41% 
Barsantini 
et al. 1946 
10 Vig Eb and .5 mg P 
per day, days 1-15 
Litter weight normal, 
pup mortality 0% 
Masson 1948 
10 yg Eb® and 5 mg P 
per day, days 1-15 
Litter weight depressed 25%, 
pup mortality 36% 
10 yg Eb and 10 mg P 
per day, days 1-15 
Litter weight depressed 42%, 
pup mortality 68% 
5 pg Eb and 5 mg P 
per day, days 1-15 
Litter weight depressed 39%, 
pup mortality 0% 
100 yg E"^ and 2.5 mg 
P per day, days 2-16 
Litter weight depressed 23%, 
pup mortality 0% 
Walker & 
Matthews 1949 
25 yg E and 2.5 mg 
P per day, days 2-16 
Litter weight depressed 4%, 
pup mortality 0% 
10 yg E and 2.5 mg 
P per day, days 2-16 
Litter weight depressed 24%, 
pup mortality 0% 
1 yg Eb and 3 mg P 
per day, days 1-14 
Litter weight normal, 
milk in mammary glands 
Griffith & 
Turner 1962 
1 yg Eb and 3 mg F 
per day, days 1-14 
Litter weight depressed 21% 
milk in mammary glands 
Knox £ 
Griffith 1970 
^stiibesterol. 
b 
P progesterone. 
*^Eb estradiol benzoate pellet, 10 mg. 
^P progesterone pellet, 40 mg. 
®Eb estradiol benzoate. 
f E estrone. 
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rats (Masson 1948; Walker and Matthews 1949). 
Lactational performance is depressed after five or six 
days of ovarian hormone treatment (Anselmino and Hoffmann 
1936). Litter growth continues after this period but at a 
slow rate. Pups whose mothers receive ovarian hormones are 
often emaciated, sluggish in movement and nurse weakly. 
Depression of lactational performance by ovarian 
hormones is not permanent. Robson (1935) reported that the 
suspension of ovarian hormone treatment during lactation re­
sulted in increased litter growth. Similar findings have been 
reported by Noble (1939) and Ben David et al^. (1965). 
The mammary gland during ovarian hormone treatment 
Griffith and Turner (1962) and Hodson (1971) observed 
that mammary gland DNA levels were not altered by estrogen-
progesterone treatment. Hodson (1971), however, observed a 
decrease in mammary gland RNA levels during estrogen-
progesterone treatment. These studies suggest maintenance of 
mammary gland size and a depression in milk production during 
ovarian hormone treatment. 
Reece- Bartlett. Hathaway and Davis (1940) reported 
increased mitotic activity in the mammary glands of lactating 
rats treated with estrogen. Gala and Reece (1962) indicated 
a dose response relationship between the amount of estrogen 
administered to lactating rats and the incidence of mitotic 
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figures. Walker and Matthews (1949) reported numerous 
cuboidal cells in the mammary glands of ovariectomized rats 
treated with estrogen. These workers suggested that the cuboidal 
cells indicated mammary gland growth rather than secretion. 
Fauvet (1941a,b) and Masson (1948) reported that the 
mammary glands regressed during estrogen^progesterone treat­
ment of £>variectomized lactating rats. Mason suggested that the 
appearance of the mammary glands was similar to that of a 
pregnant animal. Fauvet suggested the mammary gland 
appearance indicated reduced milk secretory capacity. 
Bacsich and Folley (1939) and Weichert and Kerrigan 
(1942) indicated that mammary gland morphology was not changed 
by estrogen treatment of ovariectomized rats. These investi­
gators also reported distended mammary gland alveoli con­
taining abundant amounts of milk. 
Walker (1972) reported mammary gland involution during 
estrogen-progesterone treatment of intact rats. Walker 
observed a progressive degradation of mammary gland structure 
as treatment continued. On day four of treatment Walker 
reported that the mammary gland structure was near normal 
with few collapsed alveoli. On the ni^t^ day of treatment 
twenty-five percent of the mammary gland was altered by 
estrogen-progesterone treatment. These ^ Iterations include# 
collapsed alveoli, an influx of macrophage-like cells and 
nuiRerous necrotic cells. Mammary glands examined on the 
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fourteenth day of treatment were similar in appearance to 
those examined on the ninth day of treatment, but more of 
the mammary gland was abnormal in appearance. 
Milk secretion during ovarian hormone treatment 
Many researchers report milk in the mammary glands of 
rats during ovarian hormone treatment. Knox and Griffith 
(1970), Griffith and Turner (1962) and Bruce and Ramirez 
(1970) reported that milk was present in the mammary glands 
of estrogen-progesterone rats following nursing. These 
workers also reported milk in the stomachs of the rat pups 
of estrogen-progesterone treated dams. Main (1935), Bacsich 
and Folley (1939) and Weichert and Kerrigan (1942) reported 
milk in the mammary glands of ovariectomized rats treated 
vrith estrogenic hormones, by histological and gross observa­
tion. 
Ben David et al. (1965) indicate that milk could not be 
found in the mammary glands of estrogen treated dams after 
controlled nursing trial. Hodson (1971) reported that the 
mammary glands of estrogen-progesterone dams contained less 
milk than did the mammary glands of control dams. 
As previously mentioned, many workers report the presence 
of milk in the mammary glands of ovarian hormone treated 
animals. The presence of milk in the mammary glands is the 
basis of the postulation that ovarian hormone treatment does 
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not inhibit milk secretion. In cows and goats where milk 
secretion rates can be determined directly, estrogen depresses 
milk secretion (Folley 1936, Folley and Malpress 1944, Button 
1958; Chowdhry and Forbes 1972). Workers postulating that 
ovarian hormones do not inhibit milk secretion in rats have 
either studied the effects of estrogen in ovariectomized 
rats or postulated inhibition of the milk letdown reflex. 
In ovariectomized rats there is probably no inhibition 
of milk secretion by estrogen. Estrogen-progesterone treat­
ment can depress milk secretion in ovariectomized rats. In 
intact animals estrogen and estrogen-progesterone treatment 
inhibit milk secretion. 
Mechanisms Postulated for Ovarian Hormone 
Depression of Lactational Performance 
Several mechanisms have been postulated to explain the 
inhibitory effects of ovarian hormones on lactational per­
formance. These include transmission of the steroids to the 
litter, inhibition of the milk letdown reflex, alteration of 
maternal behavior, decreased prolactin production, and 
competition between the ovarian hormones and prolactin at 
the mammary gland level. 
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Transmission of the steroid hormones to the litter 
This mechanism probably explains how large estrogen 
doses depress lactational performance in ovariectomized 
rats. Hain (1935) first demonstrated the transmission of 
ovarian hormones in milk. The evidence of hormone trans­
mission was the alteration of neonatal sex organ appearance. 
Several workers have confirmed transmission of ovarian 
hormones to litters (Walker and Stanley 1941; VJeichert and 
Kerrigan 1942). Hormone dosages used by these workers are 
far greater than dosages required to inhibit lactational 
performance in intact animals (Table 2). Estrogen decreases 
neonatal growth rates (Spencer, Gustavson and D'Amour 1931; 
Burrows 1949). Since doses of ovarian hormones capable of 
depressing lactational performance in intact animals are often 
ineffective in ovariectomized animais, it is unlikely that 
hormone transmission to the litter explains the effects of 
ovarian hormones on lactational performance, except in the 
case of ovariectomized animals treated with large amounts of 
estrogen. 
Inhibition of the milk letdown reflex 
Inhibition of the milk letdown reflex was first postu­
lated by Griffith and Turner (1962), This hypothesis has been 
repostulated by Bruce and Ramirez (1971) and Herrenkohl 
(1971). The basis of this idea is that milk is present in 
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the mammary glands after nursing. In an attempt to prove 
this hypothesis, Hodson (1971) compared suckled and unsuckled 
mammary glands of estrogen-progesterone treated animals. 
On the basis of mammary gland composition no changes in milk 
letdown were detected. 
Alteration of maternal behavior 
Hain (1935) and Weichert and Kerrigan (1942) reported 
altered maternal behavior in dams treated with estrogenic 
compounds. These workers, however, treated the dams with 
large amounts of ovarian hormones. Herrenkohl (1971) found 
no changes in maternal behavior in dams who were treated 
with progesterone during pregnancy. 
Decreased prolactin production 
Meites and Turner (1948b) reported that estrogen treat­
ment increased prolactin synthesis and elevated pituitary 
prolactin levels. Folley and associates have postulated 
on numerous occasions that low levels of estrogen stimulate 
prolactin release while high estrogen levels depress prolactin 
secretion (Folley and Malpress 1948 and Cowie and Folley 
1961). 
Chen and Meites (1970) indicated that estrogen ad­
ministration to rats in doses ranging from .1 yg per day to 
500 ug per day increased pituitary gland prolactin production 
and serum prolactin levels. Progesterone was found to reduce 
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the stimulatory effects of estrogen on both pituitary pro­
lactin and plasma titers. If estrogen levels were increased, 
the inhibitory effects of progesterone were overridden. 
Progesterone could stimulate pituitary gland prolactin 
production, presumably because of its conversion to estro­
gen. 
Single doses of estrogen, progesterone, or estrogen-
progesterone can increase plasma prolactin levels (Kalra, 
Fawcett, Krulich and McCann 1973). Doses of five, ten and 
twenty-five milligrams progesterone elevated serum prolactin 
levels. Single doses of estrogen have a similar effect, 
while estrogen-progesterone treatment has a mixed effect, at 
times stimulating prolactin release and sometimes having no 
effect. 
Since lactation is suppressed by doses of estrogen in 
the range stimulating prolactin release, it does not seem 
likely that reduced prolactin production explains the in­
hibition of lactational performance during ovarian hormone 
treatment. 
The main stimulus for prolactin secretion during lacta­
tion is the nursing stimulus, since the suspension of 
nursing is accompanied by an increase in pituitary prolactin 
levels (Meites, Sar and Voogt 1969) and suckling in­
creases plasma prolactin concentrations (Ratner and Meites 
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1964). Prolactin is also released from the pituitary gland 
in response to exteroceptive stimuli. The development of this 
reflex release mechanism takes from seven to fourteen days in 
the rat (Grosvenor, Maiweg and Mena 1969). Whether ovarian 
hormones alter the release of prolactin in response to 
nursing or exteroceptive stimuli is unknown. 
Competition between ovarian hormones and prolactin 
Nelson (1934) observed that estrogen could negate the 
lactogenic effects of anterior pituitary extracts in guinea 
pigs. If estrogen doses were lowered, lactational performance 
was re-established. In a similar study Nelson (1937) in­
duced lactation in hypophysectomized guinea pigs with 
pituitary gland extracts. If estrogen accompanied the 
pituitary extracts, lactation did not occur. These results 
indicate that endogenous prolactin production was not af­
fected by estrogen treatment and that the inhibitory effects 
of estrogen took place in the mammary gland. 
Noble (1939) found that prolactin treatment could over­
come the inhibitory effects of stilbesterol administered 
during lactation. 
Declin (1952) indicated that estrogen-progesterone 
treatment could inhibit the lactogenic effects of prolactin 
in ovariectomized rats, while progesterone had no inhibitory 
effect. 
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Meites and Sgouris (1953 and 1954) observed an antagon­
istic relationship between prolactin and estrogen-progester­
one. These researchers observed that estrogen-progesterone 
administration could block the lactogenic effects of intra­
ductal prolactin injections in rabbits. If prolactin dosages 
were increased the inhibitory effects of estrogen-progester­
one treatment were overridden. Meites and Sgouris indicated 
that both estrogen and progesterone were required to block 
the action of prolactin and that neither hormone was effective 
when administered alone against prolactin. 
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CHAPTER III. MATERIALS AND METHODS 
Introduction 
This investigation was conducted in four parts. The 
first study investigated mammary gland nucleic acid levels 
and litter growth. The second experiment was an investiga­
tion of mammary gland nucleic acid levels and litter growth, 
but in ovariectomized animals. The third project was a study 
of milk composition. The fourth study investigated mammary 
gland nucleic acid synthesis rates ^  vivo. These studies 
utilized the same hormonal treatment and the same experi­
mental design. 
Experimental Design 
The day of parturition was designated day zero of 
lactation. On day one litter size was adjusted to six pups, 
dams were assigned to experimental groups and hormonal treat­
ments were begun. Experimental animals received daily sub­
cutaneous injections of 1 yg estradiol benzoate and 3 mg 
progesterone in 0.1 ml corn oil. Injections were administered 
daily at nine P.M. Injections were continued to either day 
four or day nine of lactation. On day four or day nine the 
dams were sacrificed with ethyl ether. The abdominal inguinal 
mammary glands were removed, sealed in Kapac pouches, then 
frozen with dry ice and acetone. Mammary tissues were stored 
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at -20 C until assays were performed. 
Litters were weighed daily at 9 P.M. Pups were examined 
during weighing for injury and their abdomens were examined 
for indications of milk. Injured pups were discarded and re­
placed with pups of equal size. Ovariectomies were performed 
on day one of lactation. 
. Treatment of Animals 
Animals used in studies one and two were Sprague-Dawley 
rats from the Dan Rolfsmeyer Ccmpany. Animals used in 
studies three and four were Sprague Dawley rats from the 
SASCC Animal Company= These rats were purchased pregnant. 
Animals were kept in an artificially lighted room with 
a light cycle of fourteen hours light and ten hours dark. 
The temperature in the room was maintained at 25 C + 2 C. 
The diet was Wayne Lab Blox and water ^  libitum. Shredded 
newspaper was provided for neet material. 
Milk Collection 
One milliliter milk samples were colleeted from ran­
domly selected teats on the day of sacrifice. After col­
lection the milk samples were frozen with dry ice and 
acetone and stored at -20 C until assays were conducted. 
Milk samples were collected in the following manner. 
On the day of sacrifice pups and dams were separated for 
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twelve hours to allow milk accumulation in the mammary glands. 
Dams were then anesthetized with nembutal, and one unit of 
oxytocin was administered to cause milk letdown. The teats 
were massaged,and the milk was collected as it flowed from 
the teats with the device pictured in Figure 1. 
The milk collection device was constructed with a 
glass vial, two sixteen gauge needles, a rubber gasket fabri­
cated from a rubber plug made with a cork borer, and epoxy 
steel filler. The device was constructed by drilling two 
sixteenth inch holes in the vial cap, inserting the hypo­
dermic needles, and cementing the needles in place with 
epoxy steel filler. 
Assays 
DNA RNA analysis 
Prior to analysis mammary tissues were thawed at 4 C. 
Tissues were diced and the lipids were extracted with two 
changes of chloroform-methanol 3:1 and two changes of an­
hydrous ethyl ether. Samples were agitated continuously for 
twelve hours in each solution. After the second ether ex= 
traction, samples were stored in a fume hood so that ether 
residues could evaporate. Samples were oven dried at 50 C 
and weighed to the nearest milligram. Tissue prepared to 
this point was designated dry fat free tissue (DPFT). The 
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Figure i. Miik collection device 
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DFFT was then powdered in a Wiley mill with a number 20 
sieve. 
Nucleic acids were extracted from the DFFT by the method 
of Schneider (1945). A 25 mg sample of DFFT was combined with 
5 ml of 5% trichloroacetic acid (TCA) in a 15 ml centrifuge 
tube. The DFFT was saturated with TCA by vortex agitation. 
Samples were then heated 15 minutes at 90 C to hydrolyze the 
nucleic acids. The samples were cooled, mixed by vortex 
agitation, and the particulate matter was collected by 
centrifugation at 2,000 g for 10 minutes. The supernatant 
was decanted into a culture tube for storage. Pellets were 
resuspended in 5 ml of 5% TCA,and the digestion was repeated 
as previously described. The two supernatants were combined 
and were stored until colorimetric analysis was performed. 
DNA concentrations were measured by the diphenylamine 
reaction (Burton 1956). One ml of the nucleic acid extract 
was combined with 1 ml of IN perchloric acid and 4 ml of 
diphenylamine reagent. The samples were kept for twenty 
hours at room temperature and the optic density was measured 
at 600 nm against a reagent blank. 
RNA concentrations were determined by the orcinol reac­
tion as modified by Schneider (1945; 1957) . 
Half a milliliter of nucleic acid extract was combined 
with 4.5 ml of orcinol reagent. Samples were heated 30 
minutes at 90 C, and absorbances were measured against a 
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reagent blank at 660 nm. Both DNA and RNA standards were 
used in this procedure so that DNA contamination of the Dische 
reaction could be subtracted. 
Nucleic acid standards were prepared from a stock 
nucleic acid solution, of known phosphate concentration, 
by double serial dilution. The stock nucleic acid solution 
was prepared as follows; Nucleic acids were extracted from 
50 mg samples of commercial DNA or RNA with boiling 5% TCA. 
After the samples had cooled to room temperature, the 
nucleic acid solution was filtered through Whatman number 42 
filter paper. This solution was then diluted to 100 ml 
with 5% TCA, and the phosphate concentration was determined. 
Phosphorous analysis was conducted by the method of 
Fiske and Subbarow (1926). Five ml of the stock nucleic acid 
solution and 5 mi of 5n sulfuric acid were combined in a 
large heavy-walled test tube. Boiling beads were added, and 
the nucleic acids were digested by boiling until the solution 
was black. When no further darkening took place, a drop of 
nitric acid was added to decolorize the solution, and the ex­
cess nitric acid wag driven off by boiling. Digested samples 
were then washed into 100 ml volumetric flasks with four 10 
ml volumes of water. Ten ml of .25% ammonium molybdate and 
4 ml of amino naphthol sulfonic acid were added, and the 
flask was filled to volume with distilled water. The optic 
density was measured after 5 minutes at 700 nm against a 
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reagent blank. 
The phosphorus concentrations of the stock nucleic acids 
were compared with monopotassium phosphate standards. Five 
ml of phosphate standard, 10 ml of .25% ammonium molybdate 
in 5N sulfuric acid and 4 ml of amino naphthol sulfonic acid 
were combined in a 100 ml volumetric flask. The flask was 
filled to volume with distilled water, and the optic density 
was determined after five minutes at 700 nm. 
Amino naphthol sulfonic acid was purchased from the 
Harleco Chemical Company and was prepared with their instruc­
tions. Diphenylamine reagent was prepared by combining 1.5 
(gm) of diphenylamine, 100 ml of glacial acetic acid, .5 ml 
of acetaldehyde (18 gm/ml) and 1.5 ml of concentrated 
sulfuric acid. Orcinol reagent was prepared by combining 
.55 gm or orcinol, 55 ml of .5% ferric chloride in concen­
trated hydrochloric acid and 45 ml of 5% TCA. 
DNA RNA synthesis 
Synthesis rates of DNA and RNA were determined by 
measuring the incorporation of 14c thymidine and 3H 
uridine into DNA and RNA. On day three or day eight of 
-i:' 
the experiment, 5 yCi of 3H uridine and 5 yCi of 14C 
thymidine were administered intraperitoneal. Pups and dams 
were united and their cages placed in front of a hood to 
exhaust 14C CO2 from the building. Twelve hours later, on 
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day four or day nine, the dams and pups were sacrificed by 
ether overdose. The abdominal-inguinal mammary glands were 
removed. The mammary glands were blotted dry and weighed. 
The tissues were then quick frozen and freeze dried. The 
tissues were reweighed and were then defatted as described 
in the DNA RNA analysis section. 
Mammary glands were prepared for scintillation counting 
by first weighing the DPFT, then grinding the tissues with 
100 ml of ice cold 10% TCA in a Waring blender. The particu­
late matter was collected by centrifugation at 6,000 g for 
30 minutes in a refrigerated centrifuge. The supernatant was 
discarded, and the pellets were washed twice with 10 ml 
changes of ice cold 10% TCA. Solids were collected as 
previously described. The pellets were then dried with 
ether. 
The powdered tissues were then apportioned for DNA RNA 
analysis and for scintillation counting. Twenty-five mg 
samples of DFFT were used for DNA RNA analysis and 50 mg 
samples of DFFT were used for scintillation counting. 
The DFFT was dissolved for scintillation counting by 
combining the previously weighed sample with .3 ml of water. 
After the tissue was wet, 3.0 ml of NCS^™ (Amersham/Searle 
Corp.) tissue solubilizer was added. Digestion proceeded at 
room temperature until the samples were completely dissolved. 
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When the samples were dissolved, 15 ml of a toluene based 
scintillation fluor containing 7.2 gm of PPO and .9 gm 
POPOP per liter was added. 
Radioactivities of the samples were determined 
with a Beckman scintillation counter. The pre-programmed 
windows were used to count 14C and 3H simultaneously. 
The specific activity of thymidine and uridine were 
expressed per unit of DNA, RNA and DFFT. 
Milk assay 
Milk assay consisted of the tests listed in Table 6. 
Table 6. Methods of milk analysis 
Component Source 
1. Milk protein Nakai and Le 1970 
2o Milk fat Hallowes and Lewis 1971 
3. Total solids Hallowes and Lewis 1971 
4. Solids not fat Hallowes and Lewis 1971 
5. Lactose Slater 1957 
Milk protein was determined by combining 0.5 ml of 
milk with 5 ml of 97% acetic acid. The sample was mixed by 
vortex agitation, and, when clear, the protein concentration 
was determined by measuring absorbance at 280 nm against a 
reagent blank. Optic densities were compared with those of 
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casein standards. 
Total solids, fat, and solids-not-fat were determined 
by the following procedure. Fifty W1 of milk were placed in 
a tared vial and weighed. The sample was freeze dried, and 
the sample and vial were reweighed. The residue in the vial 
was defatted with two changes of ether, and the sample and 
vial were reweighed. 
Milk lactose assay was conducted by the following method. 
Two ml of 5% trichloroacetic acid was combined with 10 pi of 
milk. The samples were centrifuged at 15,000 g for thirty 
minutes. A 0.5 ml aliquot of the supernatant was transferred 
to a second test tube. Four ml of concentrated KCl con­
taining 1% orcinol and .05% ferric chloride was added. The 
samples were then heated at 90 C for thirty minutes. The 
samples were cooled and 2 ml of absolute ethanol was added. 
Optic densities were measured at 660 nm against a reagent 
blank. Standards were prepared from lactose monohydrate, 
and covered the 10 to 200 14g per ml range» 
Histology 
Mammary glands were examined at the light level. Tissues 
were randomly selected from the mammary glands of the dam. 
Tissues were fixed in 10% neutral buffered formalin and 
were embedded in paraplast. Sections were made at 7-10 
microns. Staining consisted of Harris hematoxylin (Humason 
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1967) and eosln. 
Uteri from randomly selected pups were examined on both 
the fourth and ninth day of the experiment. Histological 
procedures were identical to those described for the mammary 
glands. 
Vaginal smears were obtained from dams on both the 
fourth and ninth day of the experiment. The smears were 
stained with Giemsa stain (Coulombe 1970). 
Hormone Preparation 
The estrogen-progesterone solution was prepared by 
combining 3 gm of progesterone,- (Nutritional Biochemicals) 
2 ml of benzyl alcohol, 1 ml of stock estradiol and enough 
Mazola corn oil to make 100 ml of solution. This solution 
was mixed thoroughly with a magnetic stirrer to insure that 
the progesterone was dissolved. 
The stock estradiol solution was prepared by combining 
0.1 gm of estradiol benzoate, ,(Nutritional Biochemicals), 2 
ml of benzyl alcohol and enough corn oil to make 100 ml of 
solution. 
The placebo solution consisted of 98 ml of Mazola corn 
oil and 2 ml of benzyl alcohol. The estrogen-progesterone 
solution and the placebo solution were stored at room 
temperature in subdued light. 
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Statistical Analysis 
Separate analyses of variance (ANOV) were conducted on 
the mammary gland analysis data obtained on days four and 
nine. Values obtained in studies one and two were pooled for 
ANOV, while independent ANOVs were performed in studies three 
and four. Means were compared by the LSD test in studies one 
and two. In studies three and four means were compared by the 
"T" test (Snedecor and Cochran 1967). Litter weights were 
compared on the corresponding day by "T" tests. 
Mean values are shown in the data tables and graphs in 
the results chapter. Mean values are accompanied by the group 
the standard, error of the mean. 
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CHAPTER IV. RESULTS 
The mammary glands of both control and estradiol-pro-
gesterone treated animals contained milk at the time of 
sacrifice. Less milk was observed in the mammary glands of 
estradiol-progesterone treated animals on days four and 
nine. This conclusion was reached because milk flow from the 
cut surfaces of the mammary glands was more frequent and 
more extensive in control animals. Figures 2 and 3. The 
mammary glands of estradiol-progesterone treated animals were 
brown in color, while control mammary glands were cream 
colored. Figures 2 and 3. These results also suggested re­
duced quantities of milk during estradiol-progesterone treat­
ment. 
The previously mentioned differences in the mammary 
glands of control and estradiol-progesterone treated animals 
were most pronounced in study three where the pups and dams 
were separated twelve hours prior to sacrifice. In study one 
and study four the differences in mammary gland appearance 
were less marked, probably because the dams were suckled con­
tinuously prior to sacrifice. In study two, using ovariecto-
mized dams, no gross differences in the mammary glands of 
control and estradiol-progesterone treated animals were 
evident. 
Figure 2. Mammary glands from a control rat after a twelve 
hour separation from its pups on the ninth day of 
lactation. Note the large quantity of milk on 
the surface of the mammary gland and the white 
color of the mammary gland> 
Figure 3. Mammary glands from an estradiol-progesterone 
treated rat after a twelve hour separation 
from its pups on the ninth day of lactation. 
Note the brownish color of the mammary glands 
Figure 4. Mammary gland of a control rat on the fourth 
day of lactation (250X) 
Figure 5. Mammary gland of an extradiol-progesterone 
treated rat on the fourth day of lactation. 
Note the similar appearance to control mammary 
gland tissue (250X) 
49 
50 
Histological Observations 
Mammary glands from control and estrogen-progesterone 
treated animals were similar in appearance on day four. 
Figures 4 and 5. 
Mammary glands from estrogen-progesterone treated ani­
mals on the ninth day of lactation were morphologically dif­
ferent from the mammary glands of control animals. Figures 
6 to 9. Mammary glands from estrogen-progesterone treated 
animals were similar to control animals as in Figure 1, 
abnormal in appearance but secreting as in Figure 8, or 
abnormal in appearance and not secreting as in Figure 9. 
The amounts of normal, abnormal secreting and abnormal non-
secreting méimmary gland varied from rat to rat and in the 
various mammary glands of a single rat= More than half of 
the mammary gland appeared normal, twenty-five to thirty per 
cent of the mammary gland was abnormal non^secreting tissue, 
and five to ten per cent of the mammary gland was abnormal 
secreting tissue. Tissue was judged capable of secretion 
on the basis of alveolar distention. Tissue containing 
collapsed alveoli was considered non-secreting tissue. 
The abnormal secreting mammary tissue contained some 
intracellular lipid droplets. Figure 8. In many cases the 
mammary gland ducts and alveolar lumens in regions where 
abnormal secreting tissue predominated were filled with 
Figure 6. Mammary gland from a control rat on the ninth 
day of lactation (250X) 
Figures 7-9. Mammary gland from an estradiol-progesterone 
treated rat on the ninth day of lactation. 
Normal appearing mammary tissue appears in 
Figure 7. Abnormal tissue, probably capable 
of secretion appears in Figure 8. Abnormal 
tissue, probably not secreting, appears in 
Figure 9. Several collapsed alveoli are 
highlighted in Figure 9 (250X) 
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lipid droplets. The abnormal non-secreting mammary tissue 
was characterized by large numbers of intracellular and 
extracellular lipid droplets. The number of nuclei per 
alveolus was reduced in tissue of this type. Figure 9. 
Vaginal smears of control and estrogen-progesterone 
treated dams had the appearance of diestrous vaginal 
smears throughout the experiment. 
The external genitalia of the female rat pups were 
not altered by ovarian hormone treatment of their mothers. 
In no case was vaginal opening observed during the course 
of the experiment. The uteri from the pups of control and 
estrogen-progesterone treated animals were histologically 
similar on days four and nine of the experiment. 
Quantitative Observations 
Study one 
As indicated in Table 7 and Graph 1, pup weights were 
not significantly altered during the first five days of 
estrogen-progesterone treatment. A trend of reduced pup 
growth began on the fourth day of estrogen-progesterone 
treatment and continued through the experiment. By day six 
there was a significant reduction in pup weights in the es-
trogen-progesterone treated groups. 
Table 8 and Graph 2 show the results of mammary gland 
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Table 7. Mean pup weights of intact dams, study one 
1 20 6.8 6.9 
+.31 +.17 
2 20 7.3 7.6 
+.24 +.21 
3 20 8.7 8.9 
+.35 +.31 
4 20 10.0 10.5 
+.41 +.37 
5 10 11.3 11.7 
+.45 +.40 
6 10 11.4** 13.7 
+.60 +.52 
7 10 12.0** 15.4 
+.78 +.72 
8 10 12.8** 17.6 
+.82 +.58 
9 10 13.5** 19.6 
+.96 +.57 
Significant difference from control values on the 
corresponding day, P<0.01. 
DNA determinations performed in study one. Mammary gland 
DPPT weights were increased 27% by four days estradiol-
progesterone treatment, (P<0.01). Four days estradiol-
progesterone treatment increased total DNA 17% and DNA per 
hundred grams body weight 13% (P<0.01). DNA levels per mg 
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day 1 2 3 4 5 6 7 8 9 
Graph 1. Pup weights of control (C) and estradiol-
progesterone (E) treated intact animals 
Table 8. Mammary gland weights^ dam weights, and DNA levels of intact animals, study one 
Treatment Numbeir of 
Animals 
Dam vrt 
gm 
DPPr wt 
gixi 
DNA/DFFT 
yg/mg 
DNA Total 
mg 
DNA/Bwt 
mg/100 gm 
EB - P 
Day 4 
10 279 
+7.9 
1.2821** 
+.0537 
25.28 
+.7473 
31.22** 
+.8275 
11.13** 
+.3818 
Control 
Day 4 
10 279 
+12.5 
1.0551 
+.0754 
25.45 
+.8598 
26.67 
+1.233 
9.572 
+.2792 
EB - P 
Day 9 
10 286 
+9.0 
1.1980 
+.0517 
25.23 
+.9330 
29.96 
+1.179 
10.52 
+.4573 
Control 
Day 9 
10 292 
+8.0 
1.1303 
+.0591 
23.12 
+1.580 
29.36 
+2.092 
10.17 
+.6413 
** 
Significant difference from control values on the corresponding day, P<0.01. 
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Graph 2. Mammary gland DNA levels per milligram of dry fat free tissue (DFFT), 
total DNÂ in milligrams, and DNA per hundred grams body weight of 
control i[C) and estradiol-progesterone (E) intact animals, at days 4 
and 9 
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DFFT were not altered on day four. On day nine there was 
no significant difference in the DNA content of the mammary 
glands of control and estradiol-progesterone animals. 
DNA levels per mg DFFT were elevated in the estradiol-
progesterone group on day nine, suggesting a reduction in 
milk secretion due to estradiol-progesterone treatment. 
This difference was not significant. 
Mammary gland RNA levels were not altered by four days 
estradiol-progesterone treatment. Mean values obtained in 
RNA analysis are shown in Table 9 and Graph 3. Mammary 
gland RNA levels were reduced by estradiol-progesterone 
Table 9. Mammary gland RNA levels, intact animals, study one 
Treatment 
EB - P 
Day 4 
Control 
Day 4 
EB - P 
Day 9 
Control 
Day 9 
RNA/DFFT 
yg/mg 
RNA Total 
mg 
RNA/DNA 
44.65 55.61 1.787 
+1.967 +3.460 +.1230 
48.03 
+2.022 
50.27 
+3.245 
1.898 
+.0846 
50.92* 61.23** 2.031** 
+2.344 +4.480 +.0951 
60.26 
+3.625 
76-49 
+4.932 
2,657 
+.1709 
Significant difference from control values on the 
corresponding day, P<0.05. 
** 
Significant difference from control values on the 
corresponding day, P<0.01. 
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treatment on day nine. RNA per mg DFFT was reduced 15%, 
total RNA 19%, and the RNA DNA ratio 23% {P<0.01). 
Study two 
Pup weights were not significantly altered during the 
first seven days of estradiol-progesterone treatment of 
ovariectomized animals. A trend of reduced growth was evi­
dent in the estradiol-progesterone group from day five to the 
end of the experiment. On day eight the decrease in litter 
weights of the estradiol-progesterone pups was significant, 
Table 10 and Graph 4. 
Dry fat free tissue weights were not altered by 
estradiol-progesterone treatment of ovariectomized animals. 
Table 11. 
Mammary gland DNA levels were not altered by estradiol-
progesterone treatment of ovariectomized animals. Table 11 
and Graph 5. Ovariectomy prevented the increase in DNA levels 
observed in intact animals on the fourth day of treatment. 
Mammary gland RNA per milligram of DFFT, total RNA and 
the RNA DNA ratio were slightly lower in estradiol-
progesterone treated animals on days four and nine. These 
differences were not significant. Table 12 and Graph 6. 
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Table 10. Mean pup weights, ovariectomized animals, study 
two 
Day Number of 
Litters EB - P gm 
Control 
gm 
1 20 7.2 6.7 
+ .13 + .18 
2 20 7.6 7.2 
+ .18 + .27 
3 20 8.7 8.4 
+ .18 + .34 
4 20 9.9 9.8 
+ .21 +. 31 
5 10 11.5 11.7 
+ .29 + .42 
6 10 12.9 13.6 
*f • 40 + .48 
7 10 14.4 15.7 
+ .50 + .55 
O 10 15,7* 17.6 
+.60®'* +.68 
9 10 17.1** . 19.7 
+.69*' + .77 
^Significant difference from the control values of 
study one on the corresponding day, P<0.05 (see Table 7), 
* 
significant difference from control values on the 
corresponding day, P<0.05. 
significant difference from control values on the 
corresponding day, P<0.01. 
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Table 11. Mammary glêinâ weights, dam weights and DNA levels of ovariectomized animals, study two 
Treatment 
Number of 
Animals 
Dam wt 
gm 
DFFT wt 
gm 
DNA/DFFT 
yg/mg 
DNA Total 
mg 
rajA/B wt 
mg/100 gm 
EB - P 
Day 4 
Control 
Day 4 
EB - P 
Day 9 
Control 
Day 9 
10 
10 
10 
10 
276 
+9.4 
285 
+8.5 
302 
+6.8 
300 
+7.8 
.89151** 
+.0359 
a,** 
.8844 
+.0310 
1.1472 
0650 
1.1802 
+.0956 
27.29 
+1.361 
28.31 
+.8871 
27.56 
+1.641 
26.48 
+1.424 
24.41** 
+1.717 
25.86 
+.8523 
30.75 
+1.502 
30.53 
+1.413 
9.53** 
+.6030 
10.00 
+.4125 
10.32 
+.4253 
10.50 
+.2778 
Significant difference from intact control values on the corresponding day, P<0.01 (see 
Table 9). 
** 
Significant difference from intact EB - P values on the corresponding day, P<0.01 (see 
Table 9). 
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65a 
Table 12. Mammary gland RNA levels, ovariectomized animals, 
study two 
Treatment RNA/DFFT pg/mg 
RNA Total 
mg 
RNA/DNA 
EB - P 58.92 51.62 2.095 
Day 4 +2.689 +2.164 +.1422 
Control 60.13 54.65 2.130 
Day 4 +2.951 +1.284 +.1051 
EB - P 51.58 58.93** 1.905** 
Day 9 +3.410 +4.599 +.1321 
Control 56.42 65.33 2.158** 
Day 9 +2.507 +3.790 +.1091 
Significant difference from intact control values on 
the corresponding day, P<0.01 (see Table 9). 
Study three 
Hilk xrOm estràdioi-prOgêStêirOnê trêâtêd âniïïiâls appeared 
to be more viscous on both the fourth and ninth day of treat­
ment. Increased viscosity was found to be caused by an in­
crease in the solid components of the milk. Table 13 and 
Graph 7. Estradiol-progesterone treatment for four days 
elevated milk lactose concentrations 29%, milk protein 20%, 
milk fat 19%, and total milk solids 19%. These changes were 
significant (P<0.01). On the ninth day of estradiol-proges-
terone treatment the following increases in milk solids were 
observed: lactose 18%, milk protein 17%, milk fat 10%, and 
total solids 10%. These changes were significant (P<0.05). 
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TcUDle 13. Milk ccffliposition of control and estradiol--progesterone treated 
Treatment Number oi: 
Sangles 
Per cent^ 
Lactose 
Per cent^ 
Exotein 
b 
Per cent 
Fat 
Solids Not^ 
Pat 
Total^ 
Solids 
E B - P  
Day 4 
8 3.52** 
+ .28 
16.75** 
+ .41 
14.7** 
+ . 63 
20.7** 
16 
35.4** 
+1.14 
Control 
Day 4 
8 2.49 
+.11 
13.35 
+1.10 
11.8 
+ .78 
17.8 
+ .91 
29.6 
+1.59 
E B - P  
Day 9 
8 3.27* 
+ .12 
14.40* 
+.88 
11.0* 
+.57 
18.48* 
+^. 60 
29.4* 
+1.16 
Control 
Day 9 
8 2.67 
+ .10 
11.81 
+.48 
9.8 
+ .31 
16.6 
+ .42 
26.3 
+ .77 
^Percent by volume!. 
^Per cent by weight. 
Significant difference from control values on the corresponding day, P<0.05. 
Significant difference from control values on the corresponding day, P<0.01. 
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Study four 
Table 14 and Graph 8 summarize the results obtained when 
the incorporation of 14C thymidine into the mammary gland was 
measured. Thymidine incorporation was high on day four in 
both the control and estradiol-progesterone groups. On day 
nine thymidine incorporation was 76% higher in the estradiol-
progesterone treated animals (P<0.01). 
Tritiated uridine incorporation into the mammary gland 
was not affected by estradiol-progesterone treatment on day 
four. Table 15 and Graph 9. On day nine uridine incorpora­
tion was reduced 27% per unit of DFFT and 22% per 100 yg 
RNA by estradiol-progesterone treatment (P<0.05). 
Mammary gland DNA values obtained in study four are 
shown in Table 16. The day nine values are similar to those 
of study one, Table 8, except that DNA per mg of DFFT was 
increased 19% and DFFT weights were decreased 20% (P<0.01). 
These values suggest a reduction in the amount of milk 
present in the mammary glands. In study one the difference 
in mean values of these parameters between control and 
estradiol-progesterone treated animals only approached 
significance. « 
The DNA values obtained on day four in study one and 
study four were dissimilar. Control values were higher in 
study four than in study one. Estradiol-progesterone values 
were lower in study four than in study one (Table 16 and 
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Table 14. Incorporation of 14C-thymidine into mammary gland 
tissue, study four 
Treatment DPM 14C Thymidine DPM 14C Thymidine 
per mg DFFT per 100 y g DNA 
EB - P 74.4 253.1 
Day 4 +11.1 +36.9 
Control 51.6 186.3 
Day 4 +15.2 +51.3 
EB - p 95.6** 336.4** 
Day 9 +14.8 +40.4 
Control 22.1 97.0 
Day 9 +10.4 +30.9 
** 
Significant difference from control values on the 
corresponding day, P<0.01. 
Table 15. Incorporation of 3H uridine into mammary gland 
tissue, study four 
'Treatment DPM 3H Uridine per mg DFFT 
DPM 3H Uridine 
per 100 yg RNA 
EB - P 
Day 4 
40.2 
+5.2 
80.0 
+13.1 
Control 
Day 4 
31.3 
+6.3 
65.4 
+8.8 
EB - P 
Day S 
35.3* 
+4.5 
63,2* 
+7 = 1 
control 
Day 9 
48.8 
+3.5 
81.3 
+5.0 
* 
Significant difference from control values on the 
corresponding day, P<0.05. 
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estradiol-progesterone (E) treated animals, at days four and nine 
Table 16. Mammary gland weights, dam weights amd DNA levels of intact animals, study four 
Number of Dam wt DFFT wt DNA/DPFT DNA Total DNA/Bwt 
Animals gm gm Pg/mg mg mg/100 gm 
EE - P 6 263* .9648 30.57 29.53 11.35* 
Day 4 +11.1 +.0223 + .896 +1.285 + .488 
Control 8 291 1.0941 27.87 31.69 10.05 
Day 4 +13.1 +.1455 +1.219 +3.66 + .158 
DB - P 8 296 1.0623** 28.46** 30.37 10.23 
Day 9 +6.3 +.0566 +1.784 +1.73 + .447 
Control 8 294 1.3328 22.92 30.02 10.22 
Day 9 +6.6 +.0843 +1.005 + .897 + .358 
^Significant difference from control values on the corresponding day, P<0.05. 
^Significant difference from control values on the corresponding day, P<0.01. 
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8). These differences between study one and study four were 
probably due to the body weight variance of study four. 
RNA values obtained in study four were very similar 
to the RNA values obtained in study one. Table 17 and Table 9. 
On day nine total RNA was reduced 27%, and the RNA DNA ratio 
was reduced 26% by estradiol-progesterone treatment. RNA 
values on day four were equal in control and estradiol-
progesterone treated animals. 
Table 17. Mammary gland RNA levels, intact animals, study 
four 
Treatment RNA/DFPT Ug/mg 
RNA Total 
mg 
RNA/DNA 
EB - P 55.12 53.55 1.793 
Day 4 +3.57 +4.40 + .088 
Control 54.86 63.59 1.980 
Day 4 +1.46 +9.44 + .107 
EB - P 57.29 62.42** 2.066** 
Day 9 +4.00 +5.87 + .196 
Control 63.83 85.51 2.816 
Day 9 +3.12 +7.12 + .184 
itit 
significant difference from control values on the 
corresponding day, P<0.01. 
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CHAPTER V. DISCUSSION 
The general conclusion of this study is that the ovarian 
hormones estradiol and progesterone inhibit the secretion of 
milk. Ovarian hormone treatment alters the morphology of the 
mammary gland, and a heterogeneous appearance in the tissue 
develops with continued treatment. On the ninth day of 
treatment the following features were evident: isolated 
necrotic cells, non^-secrsting sectors of tissue, abnormal 
expanses of secreting tissue, and normal secreting tissue. 
These changes were not evident histologically on the fourth 
day of treatment. Biochemical changes preceding the visible 
alterations on the ninth day were probably already initiated 
on the fourth day, as indicated by altered milk composition 
on day four. Thus the existence or possible existence of a 
heterogeneous cell population during estradiol-progesterone 
treatment must be considered at all times when the results 
of this study are interpreted. 
Synergism of estrogen and progesterone is necessary for 
the inhibition of lactational performance when physiological 
concentrations of these ovarian hormones are administered. 
Previously several workers have completely removed the 
inhibitory effects of physiological doses of estrogen by 
ovariectomy of the dam (Barsantini et 1946; Masson 1948; 
Walker and Matthews 1949; Griffith and Turner 1962). 
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Synergism of estradiol and progesterone administered at 
physiological levels was indicated by litter growth inhibi­
tion observed with ovariectomized dams. Previously Knox 
and Griffith (1972) reported similar decreases in the 
lactational performance of ovariectomized dams treated with 
the levels of estradiol and progesterone used in this study. 
Ovariectomy of the dams retarded the onset of decreased 
lactational performance, decreased the extent of pup growth 
inhibition, blocked mammary gland DNA increases, and pre­
vented mammary gland RNA decreases observed in intact animals 
during estradiol-progesterone treatment. These observations 
suggested that endogenous progesterone participated in the 
inhibition of lactational performance in the intact dams. 
These observations also suggested that ovarian progesterone 
secretion was not altered by the administration of estra­
diol and progesterone in the intact animals. 
The observations made in this study in intact animals 
are believed to be due to direct effects of the hormones on 
the mammary glands of the dam. Previously transmission of 
estrogen to the pups has been suggested as the mechanism 
responsible for reduced litter growth. A concurrent altera­
tion of the pup's genitalia was noted in these studies which 
employed non-physiological hormone doses (Weichert and 
Kerrigan 1942). Alteration of the pup's genitalia was not 
observed in this study. 
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Alteration of maternal behavior has also been postu­
lated during estrogen treatment of lactating dams. Con­
current changes in the vaginal smears of the dams to the 
estrus state were noted in these studies, which employed non-
physiological levels of estrogen (Hain 1935; Weichert and 
Kerrigan 1942). In this study, the vaginal smears of the 
dams had the normal diestrous appearance characteristic of 
lactating rats throughout the ovarian hormone treatment 
period. 
The best evidence for the direct action of physiological 
levels of ovarian hormone upon the lactating mammary gland 
comes from Bruce and Ramirez (1970). These workers using 
intact rats found that estrogen implants in the mammary 
glands inhibited lactational performance, while pituitary 
estrogen implants had no effect. 
The decrease in lactational performance during the 
administration of physiological levels of estradiol and pro­
gesterone is probably caused by an alteration in the response 
of the mammary gland to endogenous prolactin. Several workers 
have shown that the local induction or maintenance of lacta­
tion induced by intraductal prolactin injections in rabbits 
can be blocked by estrogen-progesterone treatment (Meites and 
Sgouris 1953; Denamur and Delouis 1972). 
Preliminary observations made in our laboratory indicate 
that increasing the number of suckling young above a litter 
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size of six pups blocks the antilactational effects of 1 yg 
estradiol and 3 mg progesterone administered daily. These 
data can be explained by an increase in the amount of endo­
genous prolactin released in response to the stronger nursing 
stimulus of a large litter. Previously it has been shown that 
increased prolactin levels can overcome the antilactational 
effects of the ovarian steroids (Nelson 1934; Nelson 1937). 
The DNA levels reported in studies one and four were 
similar to previous reports in the literature (Griffith and 
Turner 1961; Tucker and Reece 1963). The increased mammary 
gland DNA levels reported on the fourth day of estradiol-
progesterone treatment suggest an increase in mammary gland 
growth. Mammary gland DNA levels of estradiol-progesterone 
treated animals were equal to control values on day nine when 
a large part of the mammary gland contained degenerating 
cells. 
The maintenance of mammary gland DNA levels has been 
previously reported on day fourteen of estradiol-progesterone 
treatment when more degenerating cells have been reported 
(Walker 1972; Hodson 1971; Griffith and Turner 1962). These 
data suggest that the cells lost from the mammary gland are 
replaced by mitoses. 
Thymdine incorporation into the mammary glands was 
high in both control and estradiol-progesterone treated 
animals on day four. Previously, mitotic activity and 
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mammary gland growth have been reported during the early 
part of lactation (Munford 1964; Traurig 1967; Griffith and 
Turner 1962). On day nine thymidine incorporation into the 
mammary glands of estradiol-progesterone treated animals was 
elevated above control values. These results suggested that 
the mammary gland continued to proliferate during estradiol-
progesterone treatment replacing cell losses. 
Several reports in the literature have suggested 
mammary gland growth during estrogen treatment of lactating 
rats. Gala and Reece (1962.) reported increased mitotic 
activity. Reece et al. (1940) and Walker and Matthews (1949) 
stated that the histological appearance of the mammary 
glands during estradiol treatment indicated mammary gland 
growth. ^ vitro estrogen can accelerate the mammary 
gland cell cycle (Turkington and Hill 1969). 
A logical question raised by the nucleic acid values 
obtained in this study is why are mammary gland DNA levels not 
markedly above control values during estradiol-progesterone 
treatment. The incidence of necrotic cells in the mammary 
glands on the ninth d^y reported by Walker (1972) probably 
explains why DNA levels are not elevated at this time. On 
day four DNA levels were slightly elevated in the estradiol 
progesterone treated animals when the mammary gland histological 
appearance was normal. These results suggest more rapid early 
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growth of the mammary gland during lactation. 
A finite growth response of the mammary gland to estra­
diol -progesterone treatment explains why DNA levels did not 
increase greatly above control values when the hormones 
were administered in this study. 
Previously Panda and Turner (1966) reported a finite 
limit to mammary gland growth during chronic estradiol-
progesterone treatment of rats, reached after twenty days of 
treatment. 
The finite growth of the mammary gland is probably due 
to local control mechanisms operating within the mammary 
gland. Elliot and Turner (1953) performed extensive studies 
on the mammary gland spreading factor, a hyaluronidase type 
enzyme allowing proliferation of the mammary glands into 
the fat pad of the rat. The production of this substance 
could be stimulated only for limited time periods by 
estrogen-progesterone treatment. Whether the mammary gland 
becomes refractory to the ovarian hormones and the pro­
duction of the spreading factor ceases, or whether local 
factors suppress the production of spreading factor, is 
not known. 
The growth of mammary gland ducts and alveoli are under 
local inhibitory control, which allows even spacing of these 
glandular elements. Mammary tumors do not exhibit this 
type of control, and often ducts overlap and intermesh with 
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each other (Faulkin and De Orne 1960). It is not known if 
this type of local control is similar to contact inhibi­
tion observed in tissue culture. Interestingly, mouse 
mammary gland cells transplanted into fat pads are capable 
of forming branching duct networks (Daniel and De Ome 1965). 
During the chronic administration of estrone mammary tumors 
develop within a year, suggesting that failure of local 
control mechanisms of mammary gland growth allows neoplastic 
proliferation in response to estrone (Cutts and Noble 1964). 
Local control mechanisms regulating mammary gland growth 
do not explain the isolated necrotic cells observed during 
estradiol-progesterone treatment observed in the nonsecreting 
mammary gland tissue. Local control mechanisms operate on 
alveoli and ducts rather than isolated cells. 
Mammary gland RNA values reported in this study for the 
control animals were similar to the values previously re­
ported by Tucker and Reece (1963). Decreased mammary gland 
RNA levels were observed in the estradiol-progesterone 
treated animals on day nine. Hodson (1971) observed a simi­
lar decrease in RNA on the fourteenth day of estradiol-
progesterone treatment. Uridine incorporation into the mam­
mary glands was decreased after nine days of estradiol-
progesterone treatment. The decrease in RNA levels and 
uridine incorporation observed on day nine were probably a 
result of the large amount of non-secreting mammary gland 
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tissue observed histologically at this time. This con­
clusion is supported by the day four observations of normal 
RNA levels and normal uridine incorporation when the mammary 
gland structure was normal. 
The composition of milk observed in the control animals 
on day four and nine are within the range of values reported 
in the literature for rat milk (Cox and Muller 1937; Luckey, 
Mende and Pleasants 1955; Greenbaum and Slater 1957). The 
composition of rat milk during estradiol-progesterone treat­
ment has not been studied previously. Peaker and Linzell 
(1974) reported increases in the concentrations of lactose, 
protein, immunoglobulins and fat in goat's milk during 
estrogen treatment. Hutton (1958) reported increases in the 
fat content and solids-not-fat content of cow's milk during 
estrogen treatment. The similarity of these reports to the 
observations of this study, where increases in the lactose, 
protein, and fat content of rat milk were detected, suggest 
that a similar control mechanism may be involved. Walker 
(1972) reported colostrum bodies present in the mammary gland 
cells of rats during estradiol progesterone treatment» The 
high solid content of rat milk, the colostrum bodies in the 
rat mammary gland and the immunoglobulin secretion in goats 
all suggest a colostrum like milk. Colostrum from cows, 
however, has a low lactose content (Smith 1959) , suggesting 
that the milk secreted during estradiol progesterone treatment 
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is dissimilar to colostrum. The composition of rat colostrum 
is not known. Mammary gland lactose levels are low prior to 
lactation, suggestive of a low level of lactose in rat 
colostrum (Wrenn et 1965; Shinde et a^. 1965). 
Increased milk lactose levels observed in this study 
when estradiol and progesterone were administered are 
suggestive of the increased milk lactose levels observed 
by Greenbaum and Slater (1957) during involution. These 
workers reported a decrease in milk protein concurrent with 
the lactose increase during involution, suggesting the type 
of secretion of involuting mammary glands is different from 
that observed during estradiol progesterone treatment. 
Peaker and Linzell (1974) have postulated that the in­
crease in milk solids during estrogen treatment of the 
goat 1» caused by a sodiua pump in the luminal cell mem­
branes. These workers found decreases in potassium and 
chloride ion concentrations in the milk and a concurrent 
increase in milk sodium which supports their concept. Their 
explanation for the origin of the sodium pump is less con­
vincing. They suggested that basal cell membranes formed 
pinocytotic vesicles around the immunoglobulin molecules. 
Subsequent transport of these vesicles to the luminal 
membrane deposits the sodium pump on that surface. 
Hutton (1958) considered concentration effects ob­
served in cows milk during estradiol treatment unexplainable 
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on the basis of decreased water secretion, because alkaline 
phosphatase levels were persistently elevated in the milk. 
In this study there was a tendency for the mammary gland 
alveoli of estradiol-progesterone treated animals to be 
distended more than alveoli of control animals. This dis­
tention was observed on day four and on day nine in normal 
secreting tissue. Morphometric analysis of the distention 
was not conducted. However, this distention might affect 
the concentration of the milk, by locally inhibiting blood 
flow. 
In view of the descriptive nature of the data gathered 
in this study and the weak foundations of Peaker and Linzell's 
mechanism, it seems prudent to avoid postulating a mechanism 
for the increased solid content of rat milk observed during 
éstradiol-progestercns treatment without further research= 
It can be concluded that a progesterone mediated inhi­
bition of lactose synthetase activity does not occur in the 
secreting tissue of the estradiol-progesterone treated 
animals, since milk lactose concentrations were high on both 
day four and day nine of treatment» An inhibition of lactose 
synthetase may, however, occur in the non-secreting portions 
of the mammary glands of estradiol-progesterone treated 
animals, which would not be detected by milk analysis. 
The growth of pups of intact control and estradiol-
progesterone treated dams observed in this study is similar 
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to the previous reports of Griffith and Turner (1962), Knox 
and Griffith (1970) and Hodson (1971). The reduction in 
litter growth is probably caused by decreased milk pro­
duction and the alteration in milk composition. Milk secre­
tion was not quantitatively measured in this study. The gross 
appearance of the mammary glands on day four and day nine, 
however, indicated reduced secretion. 
The litter growth observed in intact animals indicated 
that the rat pups received sufficient nourishment for growth 
during the first five days of lactation, after which they 
were undernourished. 
Alteration of mammary gland structure and the in­
creased solid content of the milk during estradiol-progester­
one treatment must be given consideration when the inhibition 
of pup growth is considered; 
It can be argued that the progressive alteration in the 
structure of the mammary glands during estradiol-progesterone 
treatment accounts for decrease in milk production and the 
concurrent decrease in litter growth. This hypothesis is not 
satisfactory,- because reduced amounts of milk and altered 
milk composition were observed on day four prior to changes 
in the histological appearance of the mammary glands. 
An effective argument can be made for incomplete milk 
removal by the weak litters of estradiol-progesterone treated 
dams, which would cause mammary gland involution and alter 
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milk composition. In cows and goats milk composition is 
altered and production rates are decreased by estradiol 
treatment even when the glands are stripped by milking 
machines (Hutton 1958; Peaker and Linzell 1974). These 
observations indicate the hypothesis of incomplete milk 
removal is incorrect. 
The most logical explanation of the litter growth rates 
observed during estradiol-progesterone treatment is that the 
milk composition and milk production are altered and decreased 
prior to the onset of litter growth depression. The pups are 
able to satisfy their nutrient and water needs initially. 
As the pups continue to grow, they cannot satisfy their in­
creasing nutrient and water requirements because of the 
limited supply of milk available from the dams. As a conse­
quence, the growth of the pups decreases to a low rate. 
As mentioned in the literature review the inhibition of 
lactational performance during ovarian hormone treatment of 
the rat can be reversed by interrupting the treatment (Ben 
David et al. 1965; Noble 1939). 
Similar observations have been made in the goat and cow 
(Hutton 1958; Peaker and Linzell 1974). In these species 
the milk composition returns to normal after a few days. 
In the rat the suspension of ovarian hormone treatment 
induces renewed litter growth. The milk composition in rats 
probably returns to normal, as in the cow and goat. The 
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mechanism for renewed growth upon the suspension of ovarian 
hormone treatment is a matter of conjecture. It may be pos­
sible for the non-secreting tissue to resume normal secretory 
activity when ovarian hormone treatment is suspended. The 
abnormal non-secreting tissue of the mammary glands contains 
many necrotic cells. There are, however, many cells which 
have the appearance of cells observed in the mammary gland 
during lactogenesis and which contain colostrum bodies 
(Walker 1972). The histological appearance of the abnormal 
non-secreting mammary tissue observed in this study was 
considered to be similar in appearance to the mammary glands 
of pregnant animals. Previously Walker and Matthews (1949) 
reached a similar conclusion. 
If the abnormal non-secreting mammary tissue contained 
in the «iaiTtmary glands of sstradicl-progssterone treated ani­
mals can resume secretion, it offers a convenient explana­
tion for the rapid recovery in lactational performance when 
ovarian hormone therapy is suspended. This conclusion is in 
agreement with the hypothesis of ovarian hormone competition 
with prolactin at the mammary gland level-
The origin of the abnormal non-secreting mammary gland 
tissue is considered to be a progressive suppression of milk 
secretion induced by estradiol and progesterone. The 
altered milk composition observed during ovarian hormone 
treatment precedes the suppression of secretion. 
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The observations made in this study of reduced milk 
secretion and concurrent mammary gland growth during estra­
diol treatment support concept of Meites that the ovarian 
hormones estradiol and progesterone inhibit lactation and 
lactogenesis at the mammary gland level. 
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SUMMARY 
The effects of estradiol-progesterone treatment on 
lactational performance of the rat were studied by measuring 
mammary gland nucleic acid levels, mammary gland nucleic 
acid synthesis, milk composition, cind tissue histology on 
the fourth and ninth days of treatment. Litter growth was 
monitored daily during the experiment. 
Estradiol-progesterone treatment inhibited the lacta­
tional performance of rats as shown by decreased litter 
growth. The depression of litter growth was less severe 
in ovariectomized dams, indicating participation of endo­
genous progesterone in the intact animals. 
Estradiol-progesterone treatment increased mammary 
gland DNA levels on day four and caused a reduction in RNA 
levels on day nine in intact animals. Ovariectomy pre­
vented these changes in nucleic acid levels. 
In intact animals the incorporation of thymidine into 
the mammary glands was stimulated by estradiol-progesterone 
treatment on day nine, but not on day four. Uridine in­
corporation was normal on day four but was reduced on day 
nine by estradiol-progesterone treatment. 
The solid components of rat milk, lactose, protein and 
fat, were increased by estradiol-progesterone treatment on 
both the fourth and ninth day. 
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Reduced milk secretion during estradiol-progesterone 
treatment was indicated by the gross appearance of the mammary 
glands on days four and nine. The histological appearance 
of the mammary glands of estradiol-progesterone treated 
animals on day nine was heterogeneous. Large portions of 
the gland were similar to control mammary glands. Con­
siderable portions of the mammary gland were, however, non-
secreting and had the appearance of mammary gland tissues of 
pregnancy. 
The results of this study indicate that the inhibition 
of lactational performance is due to decreased milk production 
which is not capable of meeting the nutritional and water 
requirements of the pups as they grow during lactation. 
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